期刊文献+

乌司他丁对体外循环心脏直视手术患者血液保护作用的临床研究 被引量:5

THE CLINICAL STUDY ON THE BLOOD PROTECTIVE EFFECT OF ULINASTATIN DURING OPEN HEART SURGERY PERFORMED WITH CARDIOPULMONARY BYPASS
下载PDF
导出
摘要 目的 探讨乌司他丁(Ulinastatin)在体外循环心脏直视手术患者围体外循环(CPB)期通过抑制纤溶酶、保护血小板的功能达到血液保护的作用。方法 选择60例CPB病人,随机分为乌司他丁组、抑肽酶组和对照组。乌司他丁为1万U/kg、抑肽酶(Aprotinin)为10万U/kg分别以生理盐水溶解稀释至20ml,对照组为20ml生理盐水,分别于麻醉诱导后经外周静脉用微量泵30min泵入。分别于麻醉后(T1)、CPB30min(T2)、手术结束(T3)、手术结束后24h(T4)4个时点自挠动脉取血,测定血浆栓溶二聚体(D-二聚体)、GpⅠb和GpⅡb/Ⅲa的浓度,记录术后胸腔引流量。结果三组血浆D-二聚体浓度于T2、T3、T4时点明显升高(P〈0.05),但组间比较乌司他丁组、抑肽酶组于T2、T3、T4时明显低于对照组(P〈0.05~0.01);GpⅠb的变化与基础值相比,对照组的其余各时点和乌司他丁组、抑肽酶组两组的T2、T3时点,均显著下降(P〈0.01),两组与对照组相比在T2、T3、T4时差异有显著性(P〈0.01);GpⅡb/Ⅲa的变化与GpⅠb的变化趋势基本一致;胸腔引流量乌司他丁组、抑肽酶组术后胸腔引流量明显少于对照组(P〈0.01)。乌司他丁组和抑肽酶组相比,各指标差异无显著性意义。结论 本实验证实,在体外循环心脏直视手术期间血液纤溶系统亢进,血小板功能受损,乌司他丁在一定程度上抑制了纤溶系统的过度激活,保护了血小板的功能.具有和抑肽酶相似的血液保护作用。 Objective To evaluate the blood protective effect of ulinastatin through restraining fibrinociase and protecting the function of platelet during open heart surgery performed with cardiopulmonary bypass(CPB). Methods Sixty patients undergoing cardiac surgery under CPB was randomly divided into three groups of twenty patients: ulinastain, aprotinin and control groups. 10000u/kg of Ulinastain and 100000u/kg of aprotinin were dissolved with 20ml saline separately. In the control group, patients received normal saline. All these drugs were given in 30 min through peripheral vein after anesthesia induced separately. Blood samples were taken immediately after anesthesia(T1 ), 30min after CPB(T2 ), at the end of operation (T3 ), and 24h after operation (T4) for determination of plasma levels of D-Dimer, GpⅠb and Gp Ⅱ b/Ⅲ a. The blood loss after operation was recorded. Re. sults The plasma levels of D-Dimer were significantly increased at T2, T3 and T4 ( P 〈 0.05) in the three groups,but in lower group U and group A are than in group(C)(P〈0.05-0.01).The levels of Gp Ⅰb significantly decreased at T2 ,T3 and T4 in group C,and at T2 ,T3 in group U and group A ( P 〈0.01) ,There is significantly difference between the two groups and group C. Conclusion The change of Gp Ⅱ b/Ⅲ a is similar to that of Gp Ⅰ b. There was significantly less postoperative blood loss in group U and group A. All index are similar in group U and group A. Ulinastain has the same protective effect on blood as aprotinin.
出处 《山东医学高等专科学校学报》 2006年第1期19-22,共4页 Journal of Shandong Medical College
基金 临沂市科技发展计划项目(No.0312106)
关键词 乌司他丁 体外循环 血液保护 Ulinastain Cardiopulmonary bypass Blood protective effect
  • 相关文献

参考文献8

  • 1[1]Holloway DS,Summaria L,Sandesara J,et al.Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients[J].Thromb Haemost,1988,59 (1):62.
  • 2[2]Hardy JF,Belisle S.Natural and synthetic antifibrinolyties in adult cardiac surgery:efficacy,effectiveness and efficiency[J].Can J Anesth,1994,41(11):1104-1112.
  • 3王庆善,张荣振,徐大庆,陈世洁,王文生,王琰.体外循环期间血浆D-二聚体的变化[J].中华胸心血管外科杂志,1998,14(1):4-6. 被引量:7
  • 4[4]Kayuthof M.Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding[J].Circulation,1994,90(1):269-274.
  • 5[5]Ray M,Marsh N,Just SJ,et al.Preoperative platelet dysfunction increase the benefit lf aprotinin in cardiopulmonary by pois[J].Arn Thorac Sung,1997,63(1):57-63.
  • 6杨光煜 张晓林 等.抑肽酶致严重过敏性休克1例[J].中华胸心血管外科杂志,1998,6(3):171-171.
  • 7张东亚,黄作本,胡小琴,刘进.小剂量抑肽酶严重过敏性休克致心室颤动一例[J].中国循环杂志,1997,12(2):153-153. 被引量:6
  • 8吉冰洋.体外循环中乌司他丁对机体的保护作用[J].中国胸心血管外科临床杂志,2002,9(1):51-53. 被引量:36

二级参考文献26

  • 1[1]Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 2[2]Conlon PJ,Stafford-Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 3[3]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery.Angiology,1998,49(10):789-800.
  • 4[4]Oshima N,Yamada T,Nakahara H,et al.Effect of ulinastatin(UL) on renal function and lactic acidosis during open-heart surgery:comparison with aprotinin.Kyobu Geka,1990,43(5):357-363.
  • 5[5]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass.Masui,1995,44(5):691-697.
  • 6[6]Yonoko S,Ueki M,Nakayo M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388-392.
  • 7[7]Ueki M,Yokono S,Komatsu H,et al.The support of postoperative renal function by ulinastatin inpatients with preoperative renal dysfunction.Masui,1995,44(4):570-573.
  • 8[8]Nakakuki M,Yamasaki F,Shinkawa T,et al.Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats.Can J Physiol Pharmacol,1996,74(1):104-111.
  • 9[9]Ueki M,Yokono S,Taie S,et al.Supplement of ulinastatin on renal function after cardiopulmonary bypass.Masui,2000,49(2):163-167.
  • 10[10]Tanita T,Song C,Kubo H,et al.Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass.Surg Today,1999,29(8):755-761.

共引文献47

同被引文献45

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部